{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:36:13Z","timestamp":1794555373862,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Multiple Sclerosis Research Center","award":["1400-1-148-52617"],"award-info":[{"award-number":["1400-1-148-52617"]}]},{"name":"Research Institute for Oncology, Hematology& Cell Therapy Facility, Shariati Hospital","award":["1400-1-233-51589"],"award-info":[{"award-number":["1400-1-233-51589"]}]},{"name":"Research Institute for Oncology, Hematology& Cell Therapy Facility, Shariati Hospital","award":["1400-1-233-51589"],"award-info":[{"award-number":["1400-1-233-51589"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-00590-6","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:04:05Z","timestamp":1746677045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cell therapy with placenta-derived mesenchymal stem cells for secondary progressive multiple sclerosis patients in a phase 1 clinical trial"],"prefix":"10.1038","volume":"15","author":[{"given":"Ameneh","family":"Shokati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6621-5424","authenticated-orcid":false,"given":"Mohsen","family":"Nikbakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roghayyeh","family":"Saeedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Asadollahzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Rezaeimanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Chahardouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Gharaylou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Asadollah","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5083-2081","authenticated-orcid":false,"given":"Jafar","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-0911","authenticated-orcid":false,"given":"Abdorreza","family":"Naser Moghadasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"590_CR1","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1038\/s41598-019-40283-5","volume":"9","author":"N Frahm","year":"2019","unstructured":"Frahm, N., Hecker, M. & Zettl, U. K. Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors. Sci. Rep. 9, 3743 (2019).","journal-title":"Sci. Rep."},{"key":"590_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s13287-021-02513-4","volume":"12","author":"M Amanat","year":"2021","unstructured":"Amanat, M. et al. Clinical and imaging outcomes after intrathecal injection of umbilical cord tissue mesenchymal stem cells in cerebral palsy: A randomized double-blind sham-controlled clinical trial. Stem Cell Res. Ther. 12, 439 (2021).","journal-title":"Stem Cell Res. Ther."},{"key":"590_CR3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s13287-021-02477-5","volume":"12","author":"A Shokati","year":"2021","unstructured":"Shokati, A. et al. A focus on allogeneic mesenchymal stromal cells as a versatile therapeutic tool for treating multiple sclerosis. Stem Cell Res. Ther. 12, 400 (2021).","journal-title":"Stem Cell Res. Ther."},{"key":"590_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/7651_2020_281","volume":"2286","author":"S Ebrahimi-Barough","year":"2021","unstructured":"Ebrahimi-Barough, S. et al. Standard operating procedure for the good manufacturing practice-compliant production of human endometrial stem cells for multiple sclerosis. Methods Mol. Biol. 2286, 199\u2013212 (2021).","journal-title":"Methods Mol. Biol."},{"key":"590_CR5","unstructured":"Torre, P.d.l., P\u00e9rez\u2010Lorenzo, M. & Flores, A.I. Human Placenta-Derived Mesenchymal Stromal Cells: A Review from Basic Research to Clinical Applications. Stromal Cells - Structure, Function, and Therapeutic Implications (2018)."},{"key":"590_CR6","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s12015-019-09917-z","volume":"15","author":"S George","year":"2019","unstructured":"George, S., Hamblin, M. R. & Abrahamse, H. Differentiation of mesenchymal stem cells to neuroglia: In the context of cell signalling. Stem Cell Rev. Rep. 15, 814\u2013826 (2019).","journal-title":"Stem Cell Rev. Rep."},{"key":"590_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059354","volume":"8","author":"ZX Yang","year":"2013","unstructured":"Yang, Z. X. et al. CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties. PLoS ONE 8, e59354 (2013).","journal-title":"PLoS ONE"},{"key":"590_CR8","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1038\/s41598-018-23396-1","volume":"8","author":"M Wu","year":"2018","unstructured":"Wu, M. et al. Comparison of the biological characteristics of mesenchymal stem cells derived from the human placenta and umbilical cord. Sci. Rep. 8, 5014 (2018).","journal-title":"Sci. Rep."},{"key":"590_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/cbin.10024","volume":"37","author":"G Wang","year":"2013","unstructured":"Wang, G. et al. Expression and biological function of programmed death ligands in human placenta mesenchymal stem cells. Cell Biol. Int. 37, 137\u2013148 (2013).","journal-title":"Cell Biol. Int."},{"key":"590_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.placenta.2017.04.003","volume":"59","author":"M Abumaree","year":"2017","unstructured":"Abumaree, M., Abomaray, F., Alshabibi, M., AlAskar, A. & Kalionis, B. Immunomodulatory properties of human placental mesenchymal stem\/stromal cells. Placenta 59, 87\u201395 (2017).","journal-title":"Placenta"},{"key":"590_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.21037\/sci-2020-034","volume":"8","author":"SE Siddesh","year":"2021","unstructured":"Siddesh, S. E. et al. Placenta-derived mesenchymal stem cells (P-MSCs) for COVID-19 pneumonia-a regenerative dogma. Stem Cell Investig. 8, 3 (2021).","journal-title":"Stem Cell Investig."},{"key":"590_CR12","doi-asserted-by":"crossref","unstructured":"Meoded, A., Poretti, A., Mori, S. & Zhang, J. Diffusion Tensor Imaging (DTI)\u2606, in Reference Module in Neuroscience and Biobehavioral Psychology (Elsevier, 2017).","DOI":"10.1016\/B978-0-12-809324-5.02472-X"},{"key":"590_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3174\/ajnr.A4946","volume":"38","author":"D Ontaneda","year":"2017","unstructured":"Ontaneda, D. et al. Measuring brain tissue integrity during 4 years using diffusion tensor imaging. AJNR Am. J. Neuroradiol. 38, 31\u201338 (2017).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"590_CR14","first-page":"205521731985603","volume":"5","author":"J Feng","year":"2019","unstructured":"Feng, J. et al. Exploratory MRI measures after intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis. Mult. Scler. J. Exp. Transl. Clin. 5, 2055217319856035 (2019).","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"590_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2022.100465","volume":"10","author":"M Amiri","year":"2023","unstructured":"Amiri, M. et al. Changes in diffusion tensor imaging indices in basal ganglia and thalamus of patients with Relapsing-Remitting Multiple Sclerosis and relation with clinical conditions: A case-control study. Eur. J. Radiol. Open 10, 100465 (2023).","journal-title":"Eur. J. Radiol. Open"},{"key":"590_CR16","first-page":"369","volume-title":"Handbook of Clinical Neurology","author":"GD Jackson","year":"2012","unstructured":"Jackson, G. D., Badawy, R. & Gotman, J. Chapter 23 - Functional magnetic resonance imaging: focus localization. In Handbook of Clinical Neurology (eds Stefan, H. & Theodore, W. H.) 369\u2013385 (Elsevier, 2012)."},{"issue":"1","key":"590_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/STROKEAHA.121.034505","volume":"53","author":"J Lee","year":"2022","unstructured":"Lee, J. et al. efficacy of intravenous mesenchymal stem cells for motor recovery after ischemic stroke: A neuroimaging study. Stroke 53(1), 20\u201328. https:\/\/doi.org\/10.1161\/STROKEAHA.121.034505 (2022).","journal-title":"Stroke"},{"key":"590_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012779","volume":"5","author":"P Ramos-Cabrer","year":"2010","unstructured":"Ramos-Cabrer, P., Justicia, C., Wiedermann, D. & Hoehn, M. Stem cell mediation of functional recovery after stroke in the rat. PLoS ONE 5, e12779 (2010).","journal-title":"PLoS ONE"},{"key":"590_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162\u2013173 (2018).","journal-title":"Lancet Neurol."},{"key":"590_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00415-020-10362-z","volume":"269","author":"CG Chisari","year":"2022","unstructured":"Chisari, C. G. et al. Rituximab for the treatment of multiple sclerosis: A review. J. Neurol. 269, 159\u2013183 (2022).","journal-title":"J. Neurol."},{"key":"590_CR21","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1177\/0091270005277075","volume":"45","author":"CM Ng","year":"2005","unstructured":"Ng, C. M., Bruno, R., Combs, D. & Davies, B. Population pharmacokinetics of rituximab (anti-CD20 monoclonal antibody) in rheumatoid arthritis patients during a phase II clinical trial. J. Clin. Pharmacol. 45, 792\u2013801 (2005).","journal-title":"J. Clin. Pharmacol."},{"key":"590_CR22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/art.21617","volume":"54","author":"MJ Leandro","year":"2006","unstructured":"Leandro, M. J., Cambridge, G., Ehrenstein, M. R. & Edwards, J. C. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. Arthrit. Rheum. 54, 613\u2013620 (2006).","journal-title":"Arthrit. Rheum."},{"key":"590_CR23","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/art.42625","volume":"75","author":"T Welte","year":"2023","unstructured":"Welte, T. et al. Identification of covariates modulating B-Cell repopulation kinetics in subjects receiving rituximab treatment. Arthrit. Rheumatol. 75, 2045\u20132053 (2023).","journal-title":"Arthrit. Rheumatol."},{"key":"590_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/7651_2020_282","volume-title":"Stem Cells and Good Manufacturing Practices: Methods, Protocols, and Regulations","author":"HR Aghayan","year":"2021","unstructured":"Aghayan, H. R. et al. GMP-Compliant Production of Human Placenta-Derived Mesenchymal Stem Cells. In Stem Cells and Good Manufacturing Practices: Methods, Protocols, and Regulations (ed. Turksen, K.) 213\u2013225 (Springer, 2021). https:\/\/doi.org\/10.1007\/7651_2020_282."},{"key":"590_CR25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s11033-024-09372-1","volume":"51","author":"A Shokati","year":"2024","unstructured":"Shokati, A. et al. Good manufacturing practices production of human placental derived mesenchymal stem cells for therapeutic applications: Focus on multiple sclerosis. Mol. Biol. Rep. 51, 460 (2024).","journal-title":"Mol. Biol. Rep."},{"key":"590_CR26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/13854046.2012.694912","volume":"26","author":"A Eshaghi","year":"2012","unstructured":"Eshaghi, A. et al. Validity and reliability of a persian translation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). Clin. Neuropsychol. 26, 975\u2013984 (2012).","journal-title":"Clin. Neuropsychol."},{"key":"590_CR27","first-page":"169","volume":"17","author":"F Akhavan Abiri","year":"2020","unstructured":"Akhavan Abiri, F. & Shairi, M. R. Validity and reliability of symptom checklist-90-revised (SCL-90-R) and brief symptom inventory-53 (BSI-53). Clin. Psychol. Person. 17, 169\u2013195 (2020).","journal-title":"Clin. Psychol. Person."},{"key":"590_CR28","first-page":"974","volume":"4","author":"M Azimian","year":"2009","unstructured":"Azimian, M., Farahani, A. S., Dadkhah, A., Fallahpour, M. & Karimlu, M. Fatigue severity scale: The psychometric properties of the persian-version in patients with multiple sclerosis. Res. J. Biol. Sci. 4, 974\u2013977 (2009).","journal-title":"Res. J. Biol. Sci."},{"key":"590_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-018-1433-7","volume":"16","author":"NH Riordan","year":"2018","unstructured":"Riordan, N. H. et al. Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis. J. Transl. Med. 16, 1\u201312 (2018).","journal-title":"J. Transl. Med."},{"key":"590_CR30","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.msard.2014.08.002","volume":"3","author":"FD Lublin","year":"2014","unstructured":"Lublin, F. D. et al. Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: A randomized, placebo-controlled, multiple-dose study. Mult. Scler. Relat. Disord. 3, 696\u2013704 (2014).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"590_CR31","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","volume":"19","author":"RHB Benedict","year":"2020","unstructured":"Benedict, R. H. B., Amato, M. P., DeLuca, J. & Geurts, J. J. G. Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues. Lancet. Neurol. 19, 860\u2013871 (2020).","journal-title":"Lancet. Neurol."},{"key":"590_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026421","volume":"9","author":"A Bogosian","year":"2019","unstructured":"Bogosian, A., Morgan, M. & Moss-Morris, R. Multiple challenges for people after transitioning to secondary progressive multiple sclerosis: A qualitative study. BMJ Open 9, e026421 (2019).","journal-title":"BMJ Open"},{"key":"590_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fresc.2022.966133","volume":"3","author":"A Bogosian","year":"2022","unstructured":"Bogosian, A. et al. Key demographics and psychological skills associated with adjustment to progressive Multiple Sclerosis early in the diagnosis. Front. Rehabil. Sci. 3, 966133 (2022).","journal-title":"Front. Rehabil. Sci."},{"key":"590_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041910","volume":"7","author":"KH Jones","year":"2012","unstructured":"Jones, K. H. et al. A large-scale study of anxiety and depression in people with Multiple Sclerosis: A survey via the web portal of the UK MS Register. PLoS ONE 7, e41910 (2012).","journal-title":"PLoS ONE"},{"key":"590_CR35","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3349\/ymj.2018.59.3.406","volume":"59","author":"JS Cho","year":"2018","unstructured":"Cho, J. S. et al. Effect of placenta-derived mesenchymal stem cells in a dementia rat model via microglial mediation: A comparison between stem cell transplant methods. Yonsei Med. J. 59, 406\u2013415 (2018).","journal-title":"Yonsei Med. J."},{"key":"590_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.490","volume":"4","author":"HM Yun","year":"2013","unstructured":"Yun, H. M. et al. Placenta-derived mesenchymal stem cells improve memory dysfunction in an A\u03b21-42-infused mouse model of Alzheimer\u2019s disease. Cell Death Dis. 4, e958 (2013).","journal-title":"Cell Death Dis."},{"key":"590_CR37","doi-asserted-by":"publisher","first-page":"205521731985603","DOI":"10.1177\/2055217319856035","volume":"5","author":"J Feng","year":"2019","unstructured":"Feng, J. et al. Exploratory MRI measures after intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis. Multiple Scler. J. Exper. Trans. Clin. 5, 2055217319856035 (2019).","journal-title":"Multiple Scler. J. Exper. Trans. Clin."},{"key":"590_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195891","volume":"13","author":"O Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez, O. et al. Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I\/II safety and feasibility study. PLoS ONE 13, e0195891 (2018).","journal-title":"PLoS ONE"},{"key":"590_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jneuroim.2010.07.013","volume":"227","author":"B Yamout","year":"2010","unstructured":"Yamout, B. et al. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study. J. Neuroimmunol. 227, 185\u2013189 (2010).","journal-title":"J. Neuroimmunol."},{"key":"590_CR40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13287-021-02248-2","volume":"12","author":"W Zhou","year":"2021","unstructured":"Zhou, W. et al. Exosomes derived from human placental mesenchymal stem cells enhanced the recovery of spinal cord injury by activating endogenous neurogenesis. Stem. Cell Res. Ther. 12, 174 (2021).","journal-title":"Stem. Cell Res. Ther."},{"key":"590_CR41","doi-asserted-by":"publisher","first-page":"e2996","DOI":"10.1038\/cddis.2017.316","volume":"8","author":"N Cao","year":"2017","unstructured":"Cao, N. et al. Clinical-grade human umbilical cord-derived mesenchymal stem cells reverse cognitive aging via improving synaptic plasticity and endogenous neurogenesis. Cell Death Dis. 8, e2996\u2013e2996 (2017).","journal-title":"Cell Death Dis."},{"key":"590_CR42","doi-asserted-by":"publisher","first-page":"e1005","DOI":"10.1212\/NXI.0000000000001006","volume":"8","author":"MA Rocca","year":"2021","unstructured":"Rocca, M. A. et al. Network damage predicts clinical worsening in multiple sclerosis: A 6.4-Year Study. Neurol. Neuroimmunol. Neuroinflamm. 8, e1005 (2021).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"590_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.brainres.2012.12.028","volume":"1497","author":"J Suzuki","year":"2013","unstructured":"Suzuki, J. et al. Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model. Brain Res. 1497, 15\u201322 (2013).","journal-title":"Brain Res."},{"key":"590_CR44","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1093\/brain\/awaa333","volume":"143","author":"P Petrou","year":"2020","unstructured":"Petrou, P. et al. Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis. Brain 143, 3574\u20133588 (2020).","journal-title":"Brain"},{"key":"590_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.expneurol.2009.08.007","volume":"223","author":"L Mazzini","year":"2010","unstructured":"Mazzini, L. et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp. Neurol. 223, 229\u2013237 (2010).","journal-title":"Exp. Neurol."},{"key":"590_CR46","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli, A., Moretta, L. & Pistoia, V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8, 726\u2013736 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"590_CR47","doi-asserted-by":"publisher","first-page":"6379161","DOI":"10.1155\/2022\/6379161","volume":"2022","author":"RK Shandil","year":"2022","unstructured":"Shandil, R. K., Dhup, S. & Narayanan, S. evaluation of the therapeutic potential of mesenchymal stem cells (MSCs) in preclinical models of autoimmune diseases. Stem. Cells Int. 2022, 6379161 (2022).","journal-title":"Stem. Cells Int."},{"key":"590_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13287-021-02165-4","volume":"12","author":"SR Hashemian","year":"2021","unstructured":"Hashemian, S. R. et al. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: A case series. Stem. Cell Res. Ther. 12, 91 (2021).","journal-title":"Stem. Cell Res. Ther."},{"key":"590_CR49","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.2174\/1389450117666160307144027","volume":"17","author":"F Kolbinger","year":"2016","unstructured":"Kolbinger, F., Huppertz, C., Mir, A. & Padova, F. D. IL-17A and multiple sclerosis: Signaling pathways, producing cells and target cells in the central nervous system. Curr. Drug. Targets 17, 1882\u20131893 (2016).","journal-title":"Curr. Drug. Targets"},{"key":"590_CR50","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","volume":"172","author":"JS Tzartos","year":"2008","unstructured":"Tzartos, J. S. et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172, 146\u2013155 (2008).","journal-title":"Am. J. Pathol."},{"key":"590_CR51","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s12276-023-00949-7","volume":"55","author":"S Jung","year":"2023","unstructured":"Jung, S. et al. Mesenchymal stem cell-derived extracellular vesicles subvert Th17 cells by destabilizing ROR\u03b3t through posttranslational modification. Exp. Mol. Med. 55, 665\u2013679 (2023).","journal-title":"Exp. Mol. Med."},{"key":"590_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.105199","volume":"80","author":"N Rezaeimanesh","year":"2023","unstructured":"Rezaeimanesh, N. et al. The correlation between serum level of interleukin-17A with cognitive impairment and disability in multiple sclerosis patients. Mult. Scler. Relat. Disord. 80, 105199 (2023).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"590_CR53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.17712\/nsj.2022.2.20210122","volume":"27","author":"YM Almatrafi","year":"2022","unstructured":"Almatrafi, Y. M. et al. Efficacy and safety of rituximab in patients with multiple sclerosis: An observational study at a tertiary center in Makkah Saudi Arabia. Neurosciences (Riyadh) 27, 65\u201370 (2022).","journal-title":"Neurosciences (Riyadh)"},{"issue":"5","key":"590_CR54","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3390\/ijms17050650","volume":"17","author":"L Fan","year":"2016","unstructured":"Fan, L. et al. Interaction between mesenchymal stem cells and B-cells. Int. J. Molecular Sci. 17(5), 650. https:\/\/doi.org\/10.3390\/ijms17050650 (2016).","journal-title":"Int. J. Molecular Sci."},{"key":"590_CR55","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/stem.1555","volume":"32","author":"S Yoshioka","year":"2014","unstructured":"Yoshioka, S. et al. CCAAT\/enhancer-binding protein \u03b2 expressed by bone marrow mesenchymal stromal cells regulates early B-cell lymphopoiesis. Stem. Cells 32, 730\u2013740 (2014).","journal-title":"Stem. Cells"},{"key":"590_CR56","doi-asserted-by":"publisher","first-page":"122","DOI":"10.26599\/JNR.2018.9040010","volume":"6","author":"Q Xue","year":"2018","unstructured":"Xue, Q. et al. The immunomodulatory function of human amniotic fluid stromal cells on B lymphocytes. J. Neurorestoratol. 6, 122\u2013133 (2018).","journal-title":"J. Neurorestoratol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00590-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00590-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00590-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T16:03:09Z","timestamp":1747065789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00590-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["590"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00590-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"12 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted according to national ethical standards and laws and have been endorsed by the Ethics Committee at Tehran university of Medical Sciences. (Ref # IR.TUMS.HORCSCT.REC.1400.007).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"16005"}}